Afonso Daniela Varela, Coelho Pedro, Miranda Luís, Fragata José
Serviço de Cirurgia Cardio-Torácica do Hospital de Santa Marta, Centro Hospitalar de Lisboa Central, Lisboa, Portugal.
Rev Port Cir Cardiotorac Vasc. 2014 Jan-Mar;21(1):27-30.
In this study we aim to assess the mortality of patients undergoing cardiac surgery and that in the post operative period required veno-venous hemofiltration.
The population studied includes 77 patients (44 men and 33 women, with mean age 67,04±12.99 years), that underwent cardiac surgery between January 2008 and March 2013, requiring veno-venous hemofiltration after surgery. 3 surgeries were urgent, 3 emergent and the other elective, 18 of which were re operations. 31 patients underwent valvular surgery, 14 myocardial revascularization surgery, 8 patients combined valvular and myocardial revascularization surgery and 22 patients other surgery. The mean EuroScore I of the study group was 15,8% (maximum of 57 and minimum of 2.2%). The mean length of stay in the intensive care unit was 18 days (maximum of 185 days and minimum of 1 day). The mean length of hospital stay was 26 days (maximum of 190 days and minimum of 1 day).
The overall mortality of the study group was 40,3% (31 patients), the hospital mortality was 31,2%(24 patients) and mortality after discharge was 9,1% (7 patients). The mean EuroScore of patients undergoing cardiac surgery alone was 5,8% and the hospital mortality was 2,8%. Mortality after 1 year follow up was 6.1%.
Patients undergoing veno-venous hemofiltration have a much higher EuroScore and mortality rate when compared to the population undergoing cardiac surgery alone. We conclude that the mortality of patients undergoing cardiac surgery and that require hemofiltration after surgery is similar to the other published studies regarding this type of patient.
在本研究中,我们旨在评估接受心脏手术患者以及术后需要静脉-静脉血液滤过患者的死亡率。
研究人群包括77例患者(44例男性和33例女性,平均年龄67.04±12.99岁),他们在2008年1月至2013年3月期间接受了心脏手术,术后需要静脉-静脉血液滤过。3例手术为急诊,3例为紧急手术,其余为择期手术,其中18例为再次手术。31例患者接受了瓣膜手术,14例接受了心肌血运重建手术,8例患者接受了瓣膜和心肌血运重建联合手术,22例患者接受了其他手术。研究组的平均欧洲心脏手术风险评估系统(EuroScore)I评分为15.8%(最高57%,最低2.2%)。在重症监护病房的平均住院时间为18天(最长185天,最短1天)。平均住院时间为26天(最长190天,最短1天)。
研究组的总体死亡率为40.3%(31例患者),医院死亡率为31.2%(24例患者),出院后死亡率为9.1%(7例患者)。单纯接受心脏手术患者的平均EuroScore评分为5.8%,医院死亡率为2.8%。1年随访后的死亡率为6.1%。
与单纯接受心脏手术的人群相比,接受静脉-静脉血液滤过的患者具有更高的EuroScore评分和死亡率。我们得出结论,接受心脏手术且术后需要血液滤过患者的死亡率与其他关于此类患者的已发表研究相似。